New report warns Beijing’s growing influence across virtually every stage of the biotech supply chain could create vulnerabilities for the US.
New report warns Beijing’s growing influence across virtually every stage of the biotech supply chain could create vulnerabilities for the US.
What the Midterm Elections mean for financial regulation: SEC deregulation, enforcement, AI investor risk, ESG disclosures, and climate risk.
The GRDP initiative will share regulatory review materials with global health authorities to accelerate access to medicines worldwide.
The agency has proposed the CRUSH rule, a package of anti-fraud measures projected to save taxpayers nearly $90 billion over 10 years.
Peter Routledge discusses the risks posed by AI, trade tensions with the United States, why Canada needs to take on more risk, and what the financial landscape might look like in 2030.
FinCEN has proposed updates to customer due diligence requirements aimed at strengthening AML safeguards and risk-based oversight.
In the November 16 letter the hospital association urged Congress to extend healthcare programs set to expire at the end of the year.
New HIPAA rule strengthens patient access to health records, supports coordinated care, and reduces provider admin requirements.